Effect of serum and oxygen concentration on gene expression and secretion of paracrine factors by mesenchymal stem cells

International Journal of Cell Biology

Volumn 2014, Issue , 2014, Pages

  Page, Patrick ^a   Dejong, Joshua ^a   Bandstra, Alaina ^b   Boomsma, Robert A ^a  

^a United States of America   (United States)

^b ILLINOIS COLLEGE OF OPTOMETRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE ISCHEMIA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXYGEN CONCENTRATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84921047340     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2014/601063     Document Type: Article

References (44)

1. R. A. Boomsma, P. D. Swaminathan, and D. L. Geenen, "Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size," International Journal of Cardiology, vol. 122, no. 1, pp. 17-28, 2007.
2. R. A. Boomsma and D. L. Geenen, "Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis," PLoS ONE, vol. 7, no. 4, Article ID e35685, 2012.
3. J. S. Burchfield and S. Dimmeler, "Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis," Fibrogenesis and Tissue Repair, vol. 1, no. 1, article 4, 2008.
4. C. C. Tsai, T. L. Yew, D. C. Yang, W. H. Huang, and S. C. Hung, "Benefits of hypoxic culture on bone marrow multipotent stromal cells," American Journal of Blood Research, vol. 2, no. 3, pp. 148-159, 2012.
5. W. E. Hoffman, R. F. Albrecht II, R. Ripper, and Z. S. Jonjev, "Brain compared to heart tissue oxygen pressure during changes in arterial carbon dioxide in the dog," Journal of Neurosurgical Anesthesiology, vol. 13, no. 4, pp. 303-309, 2001.
6. J. A. Campbell, "The influence of O2-tension in the inspired air upon the O2-tension in the tissues," The Journal of Physiology, vol. 60, no. 1-2, pp. 20-29, 1925.
7. C. C. Caldwell, H. Kojima, D. Lukashev et al. , "Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions," The Journal of Immunology, vol. 167, no. 11, pp. 6140-6149, 2001.
8. M. Khan, V. K. Kutala, D. S. Vikram et al. , "Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2129-H2139, 2007.
9. Z. Ivanovic, "Hypoxia or in situ normoxia: the stem cell paradigm," Journal of Cellular Physiology, vol. 219, no. 2, pp. 271- 275, 2009.
10. S. Ohnishi, T. Yasuda, S. Kitamura, and N. Nagaya, "Effect of hypoxia on gene expression of bonemarrow-derivedmesenchymal stem cells and mononuclear cells," Stem Cells, vol. 25, no. 5, pp. 1166-1177, 2007.
11. S.-C. Hung, R. R. Pochampally, S.-C. Chen, S.-C. Hsu, and D. J. Prockop, "Angiogenic effects of humanmultipotent stromal cell conditionedmediumactivate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis," StemCells, vol. 25, no. 9, pp. 2363-2370, 2007.
12. L. Liu, J. Gao, Y. Yuan, Q. Chang, Y. Liao, and F. Lu, "Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF," Cell Biology International, vol. 37, no. 6, pp. 551-560, 2013.
13. A. Burlacu, G. Grigorescu, A.-M. Rosca, M. B. Preda, and M. Simionescu, "Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro," Stem Cells and Development, vol. 22, no. 4, pp. 643-653, 2013.
14. J. V. Stoyanov, B. Gantenbein-Ritter, A. Bertolo et al. , "Role of hypoxia and growth and differentiation factor-5 on differentiation of human mesenchymal stem cells towards intervertebral nucleus pulposus-like cells," European Cells &Materials, vol. 21, pp. 533-547, 2011.
15. S.-P. Hung, J. H. Ho, Y.-R. V. Shih, T. Lo, and O. K. Lee, "Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells," Journal of Orthopaedic Research, vol. 30, no. 2, pp. 260-266, 2012.
16. M. Wagegg, T. Gaber, F. L. Lohanatha et al. , "Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner," PLoS ONE, vol. 7, no. 9, Article ID e46483, 2012.
17. S. Bialik, V. L. Cryns, A. Drincic et al. , "Themitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes," Circulation Research, vol. 85, no. 5, pp. 403- 414, 1999.
18. F. Bonavita, C. Stefanelli, E. Giordano et al. , "H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: inhibition by PMA," FEBS Letters, vol. 536, no. 1-3, pp. 85-91, 2003.
19. L. Grajales, J. García, K. Banach, and D. L. Geenen, "Delayed enrichment of mesenchymal cells promotes cardiac lineage and calcium transient development," Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 735-745, 2010.
20. K. H. Chua, F. Raduan, W. K. Z. W. Safwani, N. F. M. Manzor, B. Pingguan-Murphy, and S. Sathapan, "Effects of serumreduction and VEGF supplementation on angiogenic potential of human adipose stromal cells in vitro," Cell Proliferation, vol. 46, no. 3, pp. 300-311, 2013.
21. B. Follin, J. Tratwal, M. Haack-Srensen, J. J. Elberg, J. Kastrup, and A. Ekblond, "Identical effects of VEGF and serumdeprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart disease," Journal of Translational Medicine, vol. 11, article 219, 2013.
22. T. Katsuno, T. Ozaki, Y. Saka et al. , "Lowserumcultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats," Cell Transplantation, vol. 22, no. 2, pp. 287-297, 2013.
23. A. Oskowitz, H. McFerrin, M. Gutschow, M. L. Carter, and R. Pochampally, "Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic," Stem Cell Research, vol. 6, no. 3, pp. 215-225, 2011.
24. C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth, "MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of humanmesenchymal stem cells: differential regulation by inflammatory cytokines," Blood, vol. 109, no. 9, pp. 4055-4063, 2007.
25. B.-H. Jiang, G. L. Semenza, C. Bauer, and H. H. Marti, "Hypoxia- inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension," American Journal of Physiology, vol. 271, no. 4, part 1, pp. C1172-C1180, 1996.
26. R. D. Guzy and P. T. Schumacker, "Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia," Experimental Physiology, vol. 91, no. 5, pp. 807-819, 2006.
27. N. Haque, M. T. Rahman, N. H. Abu Kasim, and A. M. Alabsi, "Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy," The Scientific World Journal, vol. 2013, Article ID 632972, 12 pages, 2013.
28. C. Sanchez, A. Oskowitz, and R. R. Pochampally, "Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells," Stem Cells, vol. 27, no. 2, pp. 375-382, 2009.
29. C.-C. Tsai, P.-F. Su, Y.-F. Huang, T.-L. Yew, and S.-C. Hung, "Oct4 and Nanog directly regulate Dnmt1 to maintain selfrenewal and undifferentiated state in mesenchymal stem cells," Molecular Cell, vol. 47, no. 2, pp. 169-182, 2012.
30. L. Basciano, C. Nemos, B. Foliguet et al. , "Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status," BMC Cell Biology, vol. 12, article 12, 2011.
31. D. P. Lennon, J. M. Edmison, and A. I. Caplan, "Cultivation of ratmarrow-derivedmesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis," Journal of Cellular Physiology, vol. 187, no. 3, pp. 345-355, 2001.
32. E. Martin-Rendon, S. J. M. Hale, D. Ryan et al. , "Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia," Stem Cells, vol. 25, no. 4, pp. 1003-1012, 2007.
33. M. Shibuya, "Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases," Journal of Biochemistry, vol. 153, no. 1, pp. 13-19, 2013.
34. J. Ma, Q. Wang, T. Fei, J.-D. J. Han, and Y.-G. Chen, "MCP-1 mediates TGF-β-induced angiogenesis by stimulating vascular smooth muscle cell migration," Blood, vol. 109, no. 3, pp. 987- 994, 2007.
35. R. Salcedo, M. L. Ponce, H. A. Young et al. , "Human endothelial cells express CCR2 and respond toMCP-1: direct role ofMCP-1 in angiogenesis and tumor progression," Blood, vol. 96, no. 1, pp. 34-40, 2000.
36. S. L. Deshmane, S. Kremlev, S. Amini, and B. E. Sawaya, "Monocyte chemoattractant protein-1 (MCP-1): an overview," Journal of Interferon and Cytokine Research, vol. 29, no. 6, pp. 313-325, 2009.
37. M. Maurer and E. von Stebut, "Macrophage inflammatory protein-1," The International Journal of Biochemistry and Cell Biology, vol. 36, no. 10, pp. 1882-1886, 2004.
38. P. Menten, A. Wuyts, and J. Van Damme, "Macrophage inflammatory protein-1," Cytokine and Growth Factor Reviews, vol. 13, no. 6, pp. 455-481, 2002.
39. K. English, "Mechanisms of mesenchymal stromal cell immunomodulation," Immunology and Cell Biology, vol. 91, no. 1, pp. 19-26, 2013.
40. F. Van DenAkker, J. C. Deddens, P. A. Doevendans, and J. P. G. Sluijter, "Cardiac stem cell therapy to modulate inflammation upon myocardial infarction," Biochimica et Biophysica Acta: General Subjects, vol. 1830, no. 2, pp. 2449-2458, 2013.
41. R. Visse and H. Nagase, "Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry," Circulation Research, vol. 92, no. 8, pp. 827-839, 2003.
42. T. P. Lozito, W. M. Jackson, L. J. Nesti, and R. S. Tuan, "Human mesenchymal stem cells generate a distinct pericellular zone of MMP activities via binding of MMPs and secretion of high levels of TIMPs," Matrix Biology, vol. 34, pp. 132-143, 2014.
43. A. De Becker, P. Van Hummelen, M. Bakkus et al. , "Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase- 3," Haematologica, vol. 92, no. 4, pp. 440-449, 2007.
44. W. G. Stetler-Stevenson and D.-W. Seo, "TIMP-2: an endogenous inhibitor of angiogenesis," Trends in Molecular Medicine, vol. 11, no. 3, pp. 97-103, 2005.